Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indobufen Versus Aspirin in Endovascular Unruptured Intracranial Aneurysms Treatment

NCT07089862 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT07089862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indobufen Versus Aspirin in Endovascular Unruptured Intracranial Aneurysms Treatment
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2025
Completion date
December 31, 2026
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indobufen, unruptured intracranial aneurysm